Thought to be the next billion-dollar drug for pharmaceutical giant Bayer, Trasylol was designed to control bleeding during heart surgery. As early as the 1980s, warnings from drug researchers indicated that the drug may cause deadly side effects. However, these reports did not derail Bayer’s tenacious pursuit of FDA approval and worldwide distribution of Trasylol. The negligent release of Trasylol despite health warnings has caused thousands of patients worldwide to suffer serious injury and/or death. The personal injury lawyers and wrongful death attorneys at Phillips & Associates are dedicated to helping injured victims and their families file lawsuits against Bayer in order to obtain justice and rightful financial compensation.
In November 2007, Bayer removed Trasylol from the market after results from two scientific studies confirmed the serious dangers of the drug. The initial study, which was the largest worldwide Trasylol study ever conducted, was performed by Dr. Dennis Mangano, the same physician who warned the FDA two years ago about the serious side effects of Trasylol. In an effort to disprove Mangano’s results, Bayer hired Dr. Alexander Walker to perform an independent Trasylol study, the results of which indicated similar findings.
It took the FDA eight months to initiate the widespread recall after the physicians’ warnings. These delays in action have been estimated to cause the death of 1,000 patients each month. Bayer has been accused of withholding negative reports about Trasylol from the FDA in order to maintain profits.
The United States Food and Drug Administration (FDA) issued a public health advisory on February 8, 2006. The advisory stated that the FDA was conducting a safety evaluation for Trasylol to assess the drug’s risks. Doctors were warned to carefully weigh the potential benefits and risks of Trasylol before administering the drug to patients. The FDA advised that patients who take Trasylol should be monitored for toxicity to the kidneys, heart, and central nervous system.
Research studies have linked Trasylol to an increased risk of:
Patients who experience complications after surgery should contact their medical providers to determine if Trasylol was used during their procedure. If Trasylol was administered, the drug may have factored into post-surgical complications.
If you know someone who experienced kidney problems, heart attack, blood clot or stroke following heart surgery, contact our law firm today to schedule a free case evaluation.
While heart surgery is relatively safe, some patients experience serious complications after surgery, which can lead to further injury or even death. In these cases, use of Trasylol during surgery may be the main cause of complications. It is estimated that Trasylol was given to a third of all heart surgery patients in the United States, placing a significant number of individuals at risk.
Any patients with advanced coronary artery disease who were administered Trasylol during heart surgery may have a viable lawsuit against Bayer. If you or a loved one is experiencing post surgical complications consistent with Trasylol side effects, contact our lawyers immediately for a free case evaluation.
The dedicated personal injury attorneys at Phillips & Associates can help those injured by the side effects of defective drugs. Our law firm is committed to helping individual consumers pursue justice against giant pharmaceutical corporations. Contact Phillips & Associates today for a free case evaluation.